Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight.

Nguyen CT, Bloch Y, Składanowska K, Savvides SN, Adamopoulos IE.

Clin Immunol. 2018 Sep 6. pii: S1521-6616(18)30476-5. doi: 10.1016/j.clim.2018.09.002. [Epub ahead of print]

PMID:
30196070
2.

Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases.

Akitsu A, Iwakura Y.

Immunology. 2018 Aug 22. doi: 10.1111/imm.12993. [Epub ahead of print] Review.

PMID:
30133701
3.

A safety evaluation of guselkumab for the treatment of psoriasis.

Galluzzo M, D'Adamio S, Campione E, Bianchi L, Talamonti M.

Expert Opin Drug Saf. 2018 Jul;17(7):741-751. doi: 10.1080/14740338.2018.1488963. Epub 2018 Jul 4. Review.

PMID:
29897790
4.

Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.

Saito-Sasaki N, Sawada Y, Mashima E, Yamaguchi T, Ohmori S, Yoshioka H, Haruyama S, Okada E, Nakamura M.

Sci Rep. 2018 Apr 3;8(1):5522. doi: 10.1038/s41598-018-23623-9.

5.

Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.

Bloch Y, Bouchareychas L, Merceron R, Składanowska K, Van den Bossche L, Detry S, Govindarajan S, Elewaut D, Haerynck F, Dullaers M, Adamopoulos IE, Savvides SN.

Immunity. 2018 Jan 16;48(1):45-58.e6. doi: 10.1016/j.immuni.2017.12.008. Epub 2017 Dec 26.

PMID:
29287995
6.

IL-1β and IL-23 Promote Extrathymic Commitment of CD27+CD122- γδ T Cells to γδT17 Cells.

Muschaweckh A, Petermann F, Korn T.

J Immunol. 2017 Oct 15;199(8):2668-2679. doi: 10.4049/jimmunol.1700287. Epub 2017 Aug 30.

7.

RORγt and RORα signature genes in human Th17 cells.

Castro G, Liu X, Ngo K, De Leon-Tabaldo A, Zhao S, Luna-Roman R, Yu J, Cao T, Kuhn R, Wilkinson P, Herman K, Nelen MI, Blevitt J, Xue X, Fourie A, Fung-Leung WP.

PLoS One. 2017 Aug 1;12(8):e0181868. doi: 10.1371/journal.pone.0181868. eCollection 2017.

8.

Gene Expression Analysis of Inflammatory Cytokines in Korean Psoriatic Patients.

Chun JH, Yoon YH, Choe YB, Kang LH, Paik SY, Park CJ.

Ann Dermatol. 2017 Aug;29(4):422-426. doi: 10.5021/ad.2017.29.4.422. Epub 2017 Jun 21.

9.

Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

Eur J Clin Pharmacol. 2017 Aug;73(8):965-971. doi: 10.1007/s00228-017-2255-x. Epub 2017 Apr 25.

PMID:
28444425
10.

A Human Lin- CD123+ CD127low Population Endowed with ILC Features and Migratory Capabilities Contributes to Immunopathological Hallmarks of Psoriasis.

Mora-Velandia LM, Castro-Escamilla O, Méndez AG, Aguilar-Flores C, Velázquez-Avila M, Tussié-Luna MI, Téllez-Sosa J, Maldonado-García C, Jurado-Santacruz F, Ferat-Osorio E, Martínez-Barnetche J, Pelayo R, Bonifaz LC.

Front Immunol. 2017 Mar 2;8:176. doi: 10.3389/fimmu.2017.00176. eCollection 2017.

11.

p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.

Křížová L, Kuchař M, Petroková H, Osička R, Hlavničková M, Pelák O, Černý J, Kalina T, Malý P.

Autoimmunity. 2017 Mar;50(2):102-113. doi: 10.1080/08916934.2016.1272598. Epub 2017 Jan 19.

PMID:
28100093
12.

Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.

Guggino G, Ciccia F, Di Liberto D, Lo Pizzo M, Ruscitti P, Cipriani P, Ferrante A, Sireci G, Dieli F, Fourniè JJ, Giacomelli R, Triolo G.

Clin Exp Immunol. 2016 Dec;186(3):277-283. doi: 10.1111/cei.12853. Epub 2016 Oct 21.

13.

Candidate gene polymorphisms and risk of psoriasis: A pilot study.

Villarreal-Martínez A, Gallardo-Blanco H, Cerda-Flores R, Torres-Muñoz I, Gómez-Flores M, Salas-Alanís J, Ocampo-Candiani J, Martínez-Garza L.

Exp Ther Med. 2016 Apr;11(4):1217-1222. Epub 2016 Feb 9.

14.

Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.

Abdollahi E, Tavasolian F, Momtazi-Borojeni AA, Samadi M, Rafatpanah H.

J Immunotoxicol. 2016 May;13(3):286-300. doi: 10.3109/1547691X.2015.1115448. Epub 2016 Apr 4. Review.

PMID:
27043356
15.

Investigation of association of the IL-12B and IL-23R genetic variations with psoriatic risk in a South Indian Tamil cohort.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

Hum Immunol. 2016 Jan;77(1):54-62. doi: 10.1016/j.humimm.2015.10.006. Epub 2015 Oct 20.

PMID:
26472011
16.

Circadian Gene Clock Regulates Psoriasis-Like Skin Inflammation in Mice.

Ando N, Nakamura Y, Aoki R, Ishimaru K, Ogawa H, Okumura K, Shibata S, Shimada S, Nakao A.

J Invest Dermatol. 2015 Dec;135(12):3001-3008. doi: 10.1038/jid.2015.316. Epub 2015 Aug 20.

17.

Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Facco M, Boso D, Gatto M, Felicetti M, Frallonardo P, Ramonda R, Piva L, Zambello R, Agostini C, Scarpa R, Basso G, Semenzato G, Dayer JM, Punzi L, Doria A.

Clin Rheumatol. 2015 Sep;34(9):1571-80. doi: 10.1007/s10067-015-3002-2. Epub 2015 Jul 9.

PMID:
26152611
18.

Genetics of psoriatic arthritis.

O'Rielly DD, Rahman P.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):673-85. doi: 10.1016/j.berh.2014.10.010. Epub 2014 Nov 22. Review.

PMID:
25488777
19.

Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.

Quiniou C, Domínguez-Punaro M, Cloutier F, Erfani A, Ennaciri J, Sivanesan D, Sanchez M, Chognard G, Hou X, Rivera JC, Beauchamp C, Charron G, Vilquin M, Kuchroo V, Michnick S, Rioux JD, Lesage S, Chemtob S.

Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1216-30. doi: 10.1152/ajpregu.00540.2013. Epub 2014 Aug 20.

20.

Specific roles for dendritic cell subsets during initiation and progression of psoriasis.

Glitzner E, Korosec A, Brunner PM, Drobits B, Amberg N, Schonthaler HB, Kopp T, Wagner EF, Stingl G, Holcmann M, Sibilia M.

EMBO Mol Med. 2014 Oct;6(10):1312-27. doi: 10.15252/emmm.201404114.

Supplemental Content

Loading ...
Support Center